ReviewFrontiers in oncology2021

Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy.

Jinchun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.